162 related articles for article (PubMed ID: 11044831)
1. Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8 T cells.
Tokura Y; Yagi H; Seo N; Takagi T; Takigawa M
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):946-54. PubMed ID: 11044831
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma.
Gniadecki R; Lukowsky A
Arch Dermatol; 2005 Mar; 141(3):361-7. PubMed ID: 15781677
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma.
Nikolova M; Echchakir H; Wechsler J; Boumsell L; Bensussan A; Bagot M
Br J Dermatol; 2003 Jan; 148(1):24-9. PubMed ID: 12534590
[TBL] [Abstract][Full Text] [Related]
5. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies.
Ram-Wolff C; Martin-Garcia N; Bensussan A; Bagot M; Ortonne N
Am J Dermatopathol; 2010 Dec; 32(8):755-63. PubMed ID: 20559121
[TBL] [Abstract][Full Text] [Related]
7. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype.
Shimauchi T; Sugita K; Nakamura M; Tokura Y
Acta Derm Venereol; 2010; 90(1):68-72. PubMed ID: 20107729
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
9. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
Jakob T; Neuber K; Altenhoff J; Kowalzick L; Ring J
Acta Derm Venereol; 1996 Jan; 76(1):34-6. PubMed ID: 8721488
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
Aung PP; Climent F; Muzzafar T; Curry JL; Patel KP; Servitje O; Prieto VG; Duvic M; Jaffe ES; Torres-Cabala CA
J Cutan Pathol; 2014 Jan; 41(1):51-7. PubMed ID: 24151865
[TBL] [Abstract][Full Text] [Related]
11. CD8+ cutaneous anaplastic large-cell lymphoma: report of two cases with immunophenotyping, T-cell-receptor gene rearrangement and electron microscopic studies.
Kikuchi A; Sakuraoka K; Kurihara S; Akiyama M; Shimizu H; Nishikawa T
Br J Dermatol; 1992 Apr; 126(4):404-8. PubMed ID: 1373950
[TBL] [Abstract][Full Text] [Related]
12. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
[TBL] [Abstract][Full Text] [Related]
13. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
14. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses.
Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H
Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
18. Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Sano S; Matsui Y; Itami S; Yoshikawa K
Clin Exp Immunol; 1998 Aug; 113(2):190-7. PubMed ID: 9717967
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic/suppressor (CD8+, CD4-) cutaneous T-cell lymphoma with aggressive course.
Urrutia S; Piris MA; Orradre JL; Martinez B; Cruz MA; Garcia-Almagro D
Am J Dermatopathol; 1990 Dec; 12(6):603-6. PubMed ID: 2125178
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous γδ T-cell lymphoma with unusual immunophenotype: A case report and review of published work.
Kamijo H; Miyagaki T; Norimatsu Y; Awaji K; Oka T; Suga H; Sugaya M; Sato S
J Dermatol; 2020 Mar; 47(3):300-305. PubMed ID: 31912565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
